Brief: Cipher Pharmaceuticals Reports Qtrly Total Net Revenue Increased By 90% To $12.2 Million
28/02/2018 12:01
Feb 28 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS Q4 & FY2017 RESULTS
* CIPHER PHARMACEUTICALS INC QTRLY TOTAL NET REVENUE
INCREASED
BY 90% TO $12.2 MILLION
* CIPHER PHARMACEUTICALS INC - QTRLY INCOME FROM CONTINUING
OPERATIONS OF $0.14 PER BASIC SHARE
Source text for Eikon: ID:nCNW07LFRa
Further company coverage: CPH.TO
(Reuters.Brief@thomsonreuters.com)
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million